Nabriva Therapeutics
NBRV
$1.42
Share price
0.00%
Change (1 day)
-71.20%
Change (1 year)
Categories
Nabriva Therapeutics (NBRV) - Total liabilities
Total liabilities on the balance sheet as of March 2023 : $28.69 M
According to Nabriva Therapeutics 's latest financial reports the company's total liabilities are $28.69 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Nabriva Therapeutics - Total liabilities on balance sheet (from 2014 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $28.47 M | 3.31% |
| 2021-12-31 | $27.55 M | 8.92% |
| 2020-12-31 | $25.3 M | -52.12% |
| 2019-12-31 | $52.83 M | 26.45% |
| 2018-12-31 | $41.78 M | 205.13% |
| 2017-12-31 | $13.69 M | -14.32% |
| 2016-12-31 | $15.98 M | 69.51% |
| 2015-12-31 | $9.42 M | -77.27% |
| 2014-12-31 | $41.49 M | 35.63% |
| 2013-12-31 | $30.59 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -2.70% | 🇺🇸 USA |